Trial Profile
Mass Balance and Absolute Bioavailability Trial of cebranopadol in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Jul 2017
Price :
$35
*
At a glance
- Drugs Cebranopadol (Primary)
- Indications Back pain; Cancer pain; Diabetic neuropathies; Musculoskeletal pain
- Focus Pharmacokinetics
- 03 Jul 2017 New trial record
- 16 Jun 2017 Results assessing basic PK properties of cebranopadol by means of noncompartmental methods in six phase I clinical trials in healthy subjects published in the Clinical Pharmacokinetics